You haven't searched anything yet.
Magnolia Medical Technologies is growing our Commercial Sales team and hiring a Territory Account Manager, Atlanta. The Territory Account Managers are essential to the success of Magnolia Medical Technologies and by utilizing their expertise and experience, will ensure customer success, account retention as well as account growth, and positively impact patient outcomes.
About Us
Magnolia Medical is a young company experiencing rapid growth as a commercial-stage medical device and healthcare solutions organization offering patented technology to address challenges that have long plagued our healthcare system. Our Steripath® Initial Specimen Diversion Device® for blood collection and contamination prevention has created a new standard of care for prevention of false positive blood cultures, the gold standard diagnostic test for sepsis. Steripath® delivers significant clinical and cost savings benefits which have been extensively proven with large bodies of clinical data and peer-reviewed published studies. Based on this exceptional performance profile, we have an FDA-cleared indication for reducing blood culture contamination and uniquely provide a money-back Clinical Performance Guarantee for Steripath® to our hospital customers.
With strong institutional investor backing, we offer highly committed and qualified candidates the opportunity to be a part of building a company dedicated to dramatically improving the accuracy of sepsis diagnostics to positively impact patient outcomes and hospital economics. We know our dynamic culture, innovative technology and achievement oriented team are solving some of the hardest problems that will create value for our customers and make us invaluable for this category in healthcare.
What you do:
The Territory Account Manager (TAM) brings medical device account management experience demonstrating technical, clinical, business and economic acumen. The skills, knowledge and experience will be applied to Magnolia Medical Technologies products and market positioning of the ISDD (Initial Specimen Diversion Device), data collection, our solutions and emerging technologies.
The TAM will consistently, clearly, and passionately articulate the clinical and economic value proposition of Magnolia Medical’s product portfolio to current customers and new accounts through the TAMs guidance from the implementation stage through to account stability by performing responsibilities including:
Drive Revenue Growth
Channel Management
Training & Value Proposition Content Mastery
What you bring:
More about Magnolia Medical Technologies
Magnolia Medical Technologies develops, manufactures and markets innovative blood and bodily fluid collection devices to facilitate significant improvements in the accuracy, consistency and predictability of critical laboratory tests.
Dr. Richard Patton, the company’s co-founder and Medical Director, invented and patented the Initial Specimen Diversion Technique (ISDT™) and Initial Specimen Diversion Device (ISDD®) for blood culture collection and contamination prevention, and authored the seminal peer-reviewed publication on this technique published in the Journal of Clinical Microbiology in 2010.
The company’s flagship product, Steripath® Initial Specimen Diversion Device® for blood culture collection and contamination prevention, has been clinically proven in 17 clinical studies including 5 peer-reviewed publications to virtually eliminate the preventable error of blood culture contamination and false positive results for the diagnosis of Sepsis – delivering a reduction in false positives of up to 92% with 12-month sustained contamination rates as low as 0.2% and an average annualized cost savings of ~$1M.
Magnolia is establishing the new standard for blood culture integrity and sepsis testing accuracy with a mission to change national blood culture collection guidelines and contamination benchmarks.
The company has amassed an intellectual property portfolio including more than 70 issued method, apparatus and design patents with more than 50 additional patent applications pending. The total potential market for Magnolia’s technology exceeds $2.0 billion annually.
Magnolia Medical is committed to the continued development and successful marketing of innovative products that will transform the way healthcare is practiced around the world. The company supports this effort by offering competitive compensation, incentive packages, benefits and career growth opportunities to the most qualified candidates in the marketplace. Magnolia Medical Technologies, Inc. is an equal opportunity employer.
For more information, visit magnolia-medical.com
* Must be willing to submit to a criminal background check upon offer of employment.
** As a condition of employment with Magnolia Medical Technologies, you are required to provide proof that you are fully vaccinated against COVID-19 or qualify for a reasonable accommodation.
Full Time
Medical Technology
$84k-113k (estimate)
08/26/2024
10/25/2024
magnolia-medical.com
SEATTLE, WA
50 - 100
2006
Private
GREGORY BULLINGTON
<$5M
Medical Technology
Magnolia develops, manufactures, and markets blood and bodily fluid collection devices for the healthcare industry.